Kristine Hahn

Azacitidine: a novel agent for myelodysplastic syndromes.

J. Kolesar, M. Sullivan, Kristine Hahn, 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Clinical pharmacology and determinates of response to gefitinib in non-small cell lung cancer

J. Kolesar, M. Palmer, J. Geurink, 2004 .

Pharmacogenetics and irinotecan therapy.

James J. Wolff, J. Kolesar, Kristine Hahn, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Clinical significance of ABCB1 genotyping in oncology

J. Kolesar, Kristine Hahn, Alma Hamidovic, 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Docetaxel and irinotecan in recurrent or metastatic head and neck cancer

Ashley L. Buchanan, J. Kolesar, A. Argiris, 2009, Cancer.

Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors

G. Wilding, J. Kolesar, J. Eickhoff, 2009, Cancer Chemotherapy and Pharmacology.

Docetaxel and irinotecan in recurrent or metastatic head and neck cancer

Ashley L. Buchanan, J. Kolesar, A. Argiris, 2009, Cancer.